. 2021 Feb 19;10(4):862. doi: 10.3390/jcm10040862

Table 3.

Logistic regression analysis of the relative risk of women who have the analyzed variables of being treated with adjuvant BFB.

Variables	RR	p Value	95% C.I.		RR	p Value	76% C.I.		RR	p Value	58% C.I.
Variables	RR	p Value	Lower	Upper	RR	p Value	Lower	Upper	RR	p Value	Lower	Upper
Age	0.958	0.001	0.935	0.982	0.958	0.001	0.944	0.972	0.958	0.001	0.948	0.968
BMI	0.640	0.016	0.910	1.078	0.991	0.828	0.942	1.042	0.991	0.828	0.957	1.026
SF-36 pretreatment	0.793	0.0029	0.711	0.884	0.793	0.029	0.743	0.846	0.793	0.029	0.758	0.829
Evolution time in years	0.808	0.0011	0.711	0.918	0.808	0.001	0.748	0.872	0.808	0.001	0.766	0.852
Other pathological	0.217.	0.010	0.090	0.524	0.217	0.001	0.128	0.368	0.217	0.001	0.151	0.312
Other pharmacological treatments	0.398	0.015	0.189	0.840	1.083	0.015	0.254	0.623	0.398	0.015	0.293	0.541
Smoker	0.271	0.025	0.086	0.852	2.000	0.025	0.137	0.539	0.271	0.025	0.170	0.435
Repaired cystocele	0.330	0.046	0.111	0.980	0.330	0.046	0.172	0.634	0.330	0.046	0.211	0.517
Dystocic delivery	7.231	0.064	0.895	58.437	7.231	0.064	2.066	25.306	7.231	0.064	3.061	17.083
More 2 concurrent medical conditions	4.087	0.199	0.476	35.058	4.087	0.199	1.127	14.824	4.087	0.199	1.688	9.896
Overactive bladder	1.643	0.563	0.306	8.828	1.643	0.563	0.600	4.502	1.643	0.563	0.822	3.281
Benzodiazepine	1.576	0.315	0.649	3.827	1.576	0.315	0.926	2.682	1.576	0.315	1.094	2.270
Topical oestrogens	2.308	0.223	0.601	8.858	2.308	0.223	1.030	5.169	2.308	0.223	1.327	4.013
Amitriptyline antidepressant	0.505	0.112	0.217	1.173	0.958	0.001	0.944	0.972	0.958	0.001	0.948	0.968
Intravesical instillation of GAG	0.488	0.057	0.233	1.023	0.991	0.828	0.942	1.042	0.991	0.828	0.957	1.026
More than 2 concurrent treatments	0.287	0.0014	0.133	0.620	0.793	0.029	0.743	0.846	0.793	0.029	0.758	0.829
Other surgical interventions	0.495	0.088	0.220	1.111	0.808	0.001	0.748	0.872	0.808	0.001	0.766	0.852
More than 2 concurrent surgical interventions	0.578	0.247	0.228	1.463	0.217	0.001	0.128	0.368	0.217	0.001	0.151	0.312
SF-36 post-treatment	1.026	0.049	1000	1053	1.026	0.049	1010	1042	1.026	0.049	1.015	1.037

BFB: biofeedback of pelvic floor. RR: relative risk. CI: confidence Interval. BMI: body mass index; SF-36: value in the answers to the quality of life questionnaire SF-36. GAG: glycosaminoglycans.